India Archives - Mother on the Tower Blog

Hiding Vaccine-Related Deaths With Semantic Sleight-of-Hand#Vaccines#Family#Baby

July 21, 2017July 19, 2017 jlvranes Leave a comment

By Robert F. Kennedy, Jr.

https://worldmercuryproject.org/what-we-do/hiding-vaccine-related-deaths-semantic-sleight-hand/

The Scary Facts Most Parents Don’t Know About Vaccine Injury Compensation#Family#Android#iPad

February 20, 2015February 19, 2015 jlvranes Leave a comment

by Missy Fleugge

Vaccine injures and adverse reactions are massively under-reported, as admitted by the Centers for Disease Control. Estimates show that only one to ten percent of vaccine injuries and deaths are actually filed with the government.

In the United States, the government has created a database to keep track of hundreds of kinds of reactions to vaccinations, including fevers, soreness, seizures, swelling of the brain, arthritis, and death. Since its inception, this program has awarded over $2.5 billion to individuals and families who have suffered vaccine injury and death. These awards are funded by taxes on vaccines. [1]

Even though health care providers are required by law to report vaccine injuries, most of these adverse events are not made public in this database, known as the Vaccine Adverse Event Reporting System (VAERS). Parents may not know that common reactions to vaccines, including fevers, long bouts of crying, or rashes following vaccination should be reported to their child’s doctor. When a more serious adverse event occurs, parents may be too overwhelmed to make sure a report is filed.

Unfortunately, rather than educating doctors and parents about the importance of reporting all adverse reactions to vaccines to the VAERS database, the US government has just tightened the requirements for reporting an adverse reaction, making the process even more difficult…

Continue to the www.vactruth.com article here

Update: HPV vaccines and the Supreme Court of India#HPV#Vaccines#Android

February 10, 2015February 4, 2015 jlvranes Leave a comment

By Norma Erickson

January 2013, the government of India was ordered by their Supreme Court to file an answer to allegations put forth in a petition filed on behalf of Gramya Resource Centre for Women from Andhra Pradesh. This petition challenged the licensing of Gardasil and Cervarix for use in the private sector as well as attempts to introduce HPV vaccines for use in the public sector. The petition implicated the Drugs Controller for having licensed the vaccines without adequate research on safety and efficacy; the Health Ministry for not carrying out an enquiry into licensing of these vaccines as ordered by the Parliamentary Standing Committee on Health and Family Welfare in April 2010 and not taking any action on the report of the internal enquiry committee despite all alleged irregularities associated with the PATH project being confirmed.

October 2014, India’s Supreme Court Justices issued instructions for all petitioners and respondents in the ongoing case against to either serve the opposition with copies of affidavits filed and/or file any affidavits and rejoinder affidavits pertinent to the case within the next four weeks. The matter was then set for what was supposed to be a final hearing on January 13, 2015.

When the ’final’ hearing date arrived, several respondents had still not complied with these instructions. At least one of them went so far as to hold their two-and-a-half-foot tall affidavit for presentation to the Court on January 13th. The Honorable Supreme Court Justices did not seem to be amused.

After hearing the evidence presented on January 13th, Justices Dipak Misra and Prafulla C. Pant issued an order reminding all participants of concerns raised in a prior hearing on 12 August 2014. Those concerns are as follows:

Did the Drugs Controller of India and the ICMR (Indian Council on Medical Research) follow proper protocol for the introduction of HPV vaccines prior to the use of said vaccines in the demonstration projects in India?
What actions were taken after the submission of the Parliamentary Committee’s 72nd report on August 30, 2014?
What were the reasons for choosing certain places in Gujarat and Andhra Pradesh for the HPV vaccine demonstration projects?
What actually caused the deaths and other ailments experienced after HPV vaccine administration in said demonstration projects?
What steps were taken to monitor the safety of HPV vaccines by the Union of India and the State Governments who have an equal role in guarding the health of the nation?
Was proper consent given by the parents/guardians of all girls who were administered HPV vaccines, as the Justices been apprised?
What protocol is required to be observed/followed when this type of vaccination program is conducted?

The Honorable Supreme Court Justices deemed it appropriate to grant permission for the State of Gujarat, State of Andhra Pradesh, and State of Telangana to be added as parties to the current case.

The Justices also agreed to M/S Glaxosmithkline Asia Pvt. Ltd. and MSD Pharmaceuticals Pvt. Ltd., the companies responsible for manufacturing HPV vaccines, being served as respondents in the proceedings.

Justices Misra and Pant granted permission for the attorneys representing the petitioners to serve papers on the concerned Ethics Committees of all three States involved in the HPV demonstration projects.

In view of the fact that the above mentioned concerns had still not been adequately addressed, some respondents had failed to appear for prior hearings, and others had ignored requests for information or failed to submit affidavits in a timely manner the Justices included the following statements in the current order:

This Court hopes and trust(s) that on the next date of hearing, the Standing Counsel of all the States shall remain present and argue the matter.
The Union of India shall direct its competent authority to produce the file by which the Drugs Controller General of India approved HPV vaccines for use along with any other relevant documents to the Court and the Counsellors for the Petitioners in this case.
Learned Counsel for the Union of India shall apprise this Court what steps have been taken to comply with the recommendations put forth in the Parliamentary Committee’s Report on HPV vaccine demonstration projects in India.
Counsel for the State shall file their counter-affidavits within a period of four weeks.
The Union of India shall file their counter-affidavit (case #921/2013) within four weeks. Rejoinder affidavit, if any, within two weeks therefrom.
By the same time, rejoinder affidavit to the counter-affidavit filed by PATH International to be filed.
The Advocate for ICMR shall produce the file dealing with HPV vaccines by the next date.
Regarding the ’concept of consent’ and the resultant deaths: it has been submitted that though innovative explanations have been given stating that some girls in the States of Gujarat and Telangana expired due to snake bite and fever, in actuality, it is due to the administration of vaccinations.
It was noted that though HPV vaccines were administered for the purpose of experimentation, there is no data with regard to the adverse effects faced by the young girls.
Counsel for the Union of India, the State of Gujarat, and the State of Telangana shall state by way of affidavit what the procedure and protocols are to be followed while obtaining informed consent. The stand taken by the Union of India and the States shall be clear and in consonance with law, for the affidavit is not expected to be filed in contravention of that has been envisaged in law.
The present public interest litigation has to be perceived from the point of view of rectification and caution for the future.
The ’caution’ would convey what steps have to be taken in the future so that this kind of grievances do not arise.

In conclusion, the Supreme Court order states:

Learned counsel appearing for the Union of India and the States of Gujarat and Telangana shall file their respective affidavits keeping in view the directions given herein-above. To elucidate, the affidavit filed by the Union of India shall contain explicitly (i) what steps they intend to take on the basis of the report given by the Parliamentary Standing Committee, (ii) what is the procedure to be followed for the purposes of consent and what steps are required to be taken to find out the sufferings, if any, by the persons who were vaccinated, and (iii) the liability of compensation, if any, to be paid and whose liability it would be.

Justices set the next hearing date for April 21, 2015.

References:

India: HPV vaccines Gardasil and Cervarix make it to the Supreme Court

India: Supreme Court HPV Vaccine Controversy Continues

Original Supreme Court Documentation, go to this link – http://courtnic.nic.in/supremecourt/casestatus_new/caseno_new_alt.asp then select “Writ Petition (civil)” as the case type; 558 as the case number; and 2012 as the year. Then click submit. Follow links from there to access original documents.

Continue to the Article Here

This article in it’s entirety is compliments of www.sanevax.org

Judges demand answers after children die in controversial cancer vaccine trial in India#cdcwhistleblower#HearThisWell#Vaccines

January 21, 2015January 21, 2015 jlvranes Leave a comment

There have been over 37,000. adverse events and 214 deaths from the Gardasil/Cervarix vaccines with no evidence of any benefit from the vaccine. These figures are off of the November 2014 VAERS report and estimated to be only 1-10% of actual cases.

By GETHIN CHAMBERLAIN IN INDORE, INDIA,

Tribal girls were given shots of cervical cancer vaccines during trial
Children given Merck’s Gardasil and Cervarix vaccines
Petitioners also asked judges to investigate trials of new drug Gardasil 9
Drug has allegedly caused side-effects in children as young as nine
Investigation claims children were used as unwitting human guinea pigs
Supreme Court has given the government one month to provide answers

Judges in India’s Supreme Court have demanded answers after children died during a controversial cervical cancer vaccine trial.

Young tribal girls received shots of pharmaceutical company Merck’s Gardasil vaccine and Cervarix, manufactured by GlaxoSmithKline.

The vaccines are given to girls as young as nine in many countries – including the UK and the US – to protect against the human papilloma virus, one of the major causes of cervical cancer.

But the Indian court yesterday heard a challenge by campaigners who claim the study – funded by the Bill & Melinda Gates Foundation – failed to obtain the informed consent of the children or their parents.

They say that a ‘study’ carried out for the foundation by a US organisation was in fact an illegal drugs trial.

Continue to the Article Here

http://www.dailymail.co.uk/

India Holds Bill Gates Accountable For His Vaccine Crimes#iBelieve#Family#Vaccines

October 11, 2014October 9, 2014 jlvranes Leave a comment

by Christina England

As Bill Gates faces a lawsuit for the illegal testing of tribal children in India, it appears that his crimes against humanity have finally caught up with him.

A recent report published by Health Impact News has reported that the Gates Foundation has found itself facing a pending lawsuit, due to an investigation that is being carried out by the Supreme Courts of India.

Health Impact News stated:

“While fraud and corruption are revealed on almost a daily basis now in the vaccine industry, the U.S. mainstream media continues to largely ignore such stories. Outside the U.S., however, the vaccine empires are beginning to crumble, and English versions of the news in mainstream media outlets are available via the Internet.

One such country is India, where the Bill & Melinda Gates Foundation and their vaccine empire are under fire, including a pending lawsuit currently being investigated by the India Supreme Court.” [1]

The Health Impact News article centered largely on a four-page report that was recently published by Economic Times India.

Eager to know more, I investigated their story and discovered that the World Health Organization, the Gates Foundation and two organizations funded by them, PATH (Program for Appropriate Technology in Health) and GAVI (Global Alliance for Vaccines and Immunization), have found themselves under fire…

Coninue to the Full Article Here

www.vactruth.com

India: Supreme Court HPV Vaccine Controversy Continues#Vaccines#HPV#iBelieve

August 23, 2014August 22, 2014 jlvranes Leave a comment

By Norma Erickson

New Delhi: A petition currently before the Supreme Court alleges that the Drugs Controller of India issued licenses for Gardasil and Cervarix without adequate research on safety. The Parliamentary Standing Committee on Health and Family Welfare had asked for a premier investigating agency to enquire into it way back in 2010 and no action has been taken on it.

Petition number 558/2012, filed by Kalpana Mehta, Nalini Bhanot and V. Rukmini Rao, seeks to resolve this and several other issues by asking the Supreme Court of India to rescind the licenses for marketing and administration of HPV vaccines, make provisions to identify and treat any girls left with chronic health problems and/or autoimmune disorders after their participation in HPV vaccine trials, and strengthen the regulation of the Program for Appropriate Technology in Health (PATH) and other foreign NGOs so that they do not flout the laws of the country with such impunity.

12 August 2014, Supreme Court Judges Dipak Misra and V. Gopala Gowda allowed Gujarat, Andhra Pradesh and Telangana to be named as respondents in the case because some villages in these states were chosen for administering HPV vaccines as an experiment and reports estimate 1200 girls were left suffering from adverse reactions to Gardasil and Cervarix.

The judges directed government agencies to produce the file(s) relating to licensing of Gardasil and Cervarix, the report(s) of the Parliamentary Standing Committee on Health and Family Welfare which dealt with issues relating to HPV vaccines, and any files from the Indian Council of Medical Research dealing with HPV vaccines.

The judges want to examine whether proper protocol and procedures were followed prior to the introduction of HPV vaccines.

They also wish to see what action was taken after the parliamentary committee submitted its report and what the reasons were for choosing the specific locations in Gujarat, Andhra Pradesh and Telangana for introducing Gardasil and Cervarix on an experimental basis.

The Court seeks to know what actually caused the deaths of some participants in the demonstration projects/clinical trials and whether proper consent was obtained from the girls and/or their families prior to their participation in the experiment.

MSD Pharmaceuticals Pvt. Ltd. (subsidiary of Merck) and GlaxoSmithKline Ltd. were served notices.

Judges Misra and Gowda set the case for final hearing on October 28, 2014.

HPV Vaccine History in India:

2006: As part of a four-nation initiative against cervical cancer, PATH decided to launch ‘demonstration projects’ for the HPV vaccination in Peru, Uganda, Vietnam and India, using a grant of $27.8 million from the Bill and Melinda Gates Foundation. This decision was made by PATH with funding granted two years before HPV vaccines were approved for use in India.
2008: Gardasil and Cervarix were approved for marketing in India, allegedly without following the standard government protocol for vaccine approval in the country.
July and August 2009: The Andhra Pradesh and Gujarat governments, in association with the Indian Council of Medical Research (ICMR) and the Program for Appropriate Technology in Health (PATH), launched what they described as a ‘demonstration project’ for vaccination against cervical cancer.
During these demonstration projects: Gardasil, manufactured by Merck Sharpe & Dohme (India) Pharmaceuticals Private Limited (MSD), was administered to 13,791 girls in Khammam district in Andhra Pradesh. Cervarix, manufactured by GlaxoSmithKline Biologicals (GSK) of Rixensart, Belgium, was administered to 9,637 girls in Vadodara district in Gujarat. An estimated 5% of those who participated were left with chronic health problems and/or autoimmune disorders.
Concurrently: Women’s groups, health networks, human rights groups and child rights groups in India voiced concerns about the safety, efficacy and public health value of both vaccines. Many joint memoranda enumerating these concerns were submitted to the Union Minister for Health and Family Welfare demanding an immediate halt to the demonstration projects.
2010: The Ministry of Health and Family Welfare (MOHFW) conceded that the HPV vaccination project was in fact a “post-licensure operational research study.” The Indian Council of Medical Research (ICMR) admitted that their ethical guidelines had been flouted in the course of this trial. The trial was temporarily suspended by the government, and a committee formed to conduct an inquiry.
The investigation revealed the so-called ‘demonstration project’ to be a calculated, multi-level violation of all existing protocol on clinical trials, as well as a glaring breach of children’s rights.
2012: Ultimately, the suspension and subsequent investigations allowed advocates in India to take their case to the Supreme Court. The Writ of Petition (#558/2012) was filed asking that the licenses for sale and marketing of both HPV vaccines be revoked because Gardasil and Cervarix are unsafe and the permits were granted without adequate research.
2013: The petition for the case was formally admitted by the judges on January 7, 2013. By September 2013, the court had issued notices to all participants involved while the Indian Parliament issued a scathing comment condemning all organizations involved in the so-called ’demonstration projects’ calling them a case of child abuse expressly carried out to create a market for the two companies – Merck and GlaxoSmithKline.
The Supreme Court issued notices to the Government of India and the Drugs Controller asking for their responses to the allegations in January 2013. By September, neither had bothered to file a reply.
2014: As a result of continued investigations regarding clinical trials involving HPV vaccines in India, additional allegations of unethical conduct were lodged against Merck. The allegations pertain to Merck’s recent trials of the new V503 HPV vaccine, a proposed nine valent HPV vaccine. The additional allegations of multiple ethics violations were added to the currently ongoing Supreme Court Case via an affidavit added as an addendum to the brief previously prepared regarding the ’demonstration projects’
According to a press release written by Kalpana Mehta, Nalini Bhanot and V. Rukmini Rao, there is documentary evidence that though PATH is a non-governmental organization (NGO), in this case it entered into a business agreement with Merck so Merck would have a ready market for HPV vaccines in resource poor countries. In fact PATH got funding for this purpose from the Bill & Melinda Gates Foundation in the same month that Gardasil was licensed in the USA, June 2006.
12 August 2014: Supreme Court Judges Dipak Misra and V. Gopala Gowda sent notices to several respondents requesting further information as outlined above and set the petition for final hearing on October 28, 2014.

Will India be the first country in the world to revoke the marketing licenses for Gardasil and Cervarix?

Will the Supreme Court of India move to protect the health and welfare of their young citizens, or the interests of the HPV vaccine manufacturers?

Will PATH and similar agencies be banned from operating in India?

Will the victims of adverse reactions to HPV vaccines be located, treated and compensated for being forced to participate in a trial that violated their human rights?

Perhaps these questions will be answered on October 28^th.

Article in it’s entirety is compliments of SaneVax.org

Sources:

Did WHO promote vaccines in India not in use in other countries? #Vaccines #Adverse Reactions To Vaccines #WHO Corruption

August 29, 2013January 29, 2014 jlvranes Leave a comment

Did WHO promote vaccines in India not in use in other countries?

ABSTRACT

New Delhi, July 22 (IANS) A leading Indian journal of medical ethics has charged the World Health Organisation (WHO) of promoting a vaccine in this country that has been discontinued elsewhere, following adverse reactions and deaths in children.